CD34 Selection of the Peripheral Blood Stem Cell Graft for Autologous Transplant

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

99

Participants

Timeline

Start Date

September 30, 1996

Primary Completion Date

June 30, 2005

Study Completion Date

June 30, 2005

Conditions
Breast Cancer
Interventions
PROCEDURE

high dose chemo then auto hematopoietic cell transplant

Trial Locations (1)

94305

Stanford University School of Medicine, Stanford

All Listed Sponsors
lead

Stanford University

OTHER

NCT00186680 - CD34 Selection of the Peripheral Blood Stem Cell Graft for Autologous Transplant | Biotech Hunter | Biotech Hunter